Personal Stories, Headlines & Helpful Information, Research, Dollars Making A Difference
By: Amanda Oberstein
Breast cancer is the #1 cause of cancer deaths for women
20-59 in the United States, killing more than 42,000 people each year. Most of
these deaths are due to Stage IV metastatic
breast cancer (or MBC). MBC is cancer that
has spread from the breast to other areas in the body and is the most advanced stage
of the disease. Understanding what causes breast cancer to metastasize (spread)
and developing new treatments for MBC is an imperative component in achieving
our Bold Goal: to reduce the current number of breast cancer deaths in the U.S.
by 50% by 2026.
Dr. Kevin Cheung has dedicated his career to stopping MBC.
Dr. Cheung is a clinician-scientist at the Fred Hutchinson Cancer Research
Center in Seattle, WA. He shares, “As a clinician, my most important responsibility
is to protect my patients from this terrible disease. That means thinking hard about balancing the
risks and benefits of treatment and what we can do today – not many years in
the future – to extend quality and quantity of life.“ Dr. Cheung too often sees
MBC patients whose treatment
options fail. Therefore, he is devoted to making discoveries that
will help predict which cases of breast cancer will metastasize and developing more
efficient treatment options to stop metastasis and improve patient survival.
Research shows that people who have clusters
of tumor cells circulating in their blood are more likely to die
from MBC. Other studies show that tumor cell clusters are present in the circulation
of ~20 percent of people living with MBC, and the likelihood of finding
clusters increases as patients progress on therapy. Furthermore, tumor cell
clusters appear to be better at resisting cancer therapy and forming new
metastases compared with single tumor cells. These factors could explain why
some people with circulating tumor cell clusters are more likely to die of
their disease than those without clusters. Although there appears to be a
strong relationship between tumor cell clusters and MBC, there is still much
that we do not know.
A major focus of Dr. Cheung’s laboratory is preventing tumor
cells from clustering in the first place. His work indicates that certain
proteins may play a key role in helping tumor cells cluster together and
survive. Consider these proteins the ‘sticky tape of the cell.’ Dr. Cheung and
other researchers have shown that if this sticky adhesion is broken, tumor cell
clusters break apart and are less likely to metastasize. By targeting specific ‘sticky
tape’ proteins with drug treatments, Dr. Cheung hopes to show this strategy can
eliminate tumor cell clusters and stop metastasis. The results of his work
could offer hope for those living with breast cancer. “These are early days in
our research, but we hope this work will one day lead to new kinds of therapies
and predictive markers for MBC patients,” says Dr. Cheung.
In addition to his exciting work in the lab, Dr. Cheung
believes volunteering is an integral component of ending breast cancer forever.
He is heavily involved in his local Komen Affiliate, Komen Puget Sound. Dr.
Cheung says, “Whether it’s sharing about our work with our local Komen Puget
Sound affiliate or educating patients at the Northwest Metastatic Breast Cancer
Conference, I am inspired by the thriving community of advocates in the Seattle
area. We are all part of something bigger - working together to eradicate
Return to Blog Home